Population toxicokinetics of tetrachloroethylene

被引:51
作者
Bois, FY
Gelman, A
Jiang, J
Maszle, DR
Zeise, L
Alexeef, G
机构
[1] US EPA,CAL,OFF ENVIRONM HLTH HAZARD ASSESSMENT,BERKELEY,CA 94704
[2] UNIV CALIF BERKELEY,DEPT STAT,BERKELEY,CA 94720
[3] UNIV CALIF BERKELEY,UCB UCSF JOINT GRAD GRP BIOENGN,BERKELEY,CA 94720
关键词
human metabolism; pharmacokinetics; population toxicokinetics; tetrachloroethylene;
D O I
10.1007/s002040050284
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
In assessing the distribution and metabolism of toxic compounds in the body, measurements are not always feasible for ethical or technical reasons. Computer modeling offers a reasonable alternative, but the variability and complexity of biological systems pose unique challenges in model building and adjustment. Recent tools from population pharmacokinetics, Bayesian statistical inference, and physiological modeling can be brought together to solve these problems. As an example, we modeled the distribution and metabolism of tetrachloroethylene (PERC) in humans. We derive statistical distributions for the parameters of a physiological model of PERC, on the basis of data from Monster et al. (1979). The model adequately fits both prior physiological information and experimental data. An estimate of the relationship between PERC exposure and fraction metabolized is obtained. Our median population estimate for the fraction of inhaled tetrachloroethylene that is metabolized, at exposure levels exceeding current occupational standards, is 1.5% [95% confidence interval (0.52%, 4.1%)]. At levels approaching ambient inhalation exposure (0.001 ppm), the median estimate of the fraction metabolized is much higher, at 36% [95% confidence interval (15%, 58%)]. This disproportionality should be taken into account when deriving safe exposure limits for tetrachloroethylene and deserves to be verified by further experiments.
引用
收藏
页码:347 / 355
页数:9
相关论文
共 45 条
[1]   QUANTITATIVE RELATIONS IN THE PHYSIOLOGICAL CONSTITUTIONS OF MAMMALS [J].
ADOLPH, EF .
SCIENCE, 1949, 109 (2841) :579-585
[2]  
ALEXEEFF GV, 1992, HLTH EFFECTS PERCHLO
[3]   PHYSIOLOGICAL PHARMACOKINETICS AND CANCER RISK ASSESSMENT [J].
ANDERSEN, ME ;
KREWSKI, D ;
WITHEY, JR .
CANCER LETTERS, 1993, 69 (01) :1-14
[4]  
[Anonymous], MODELING INHALATION
[5]   PHYSIOLOGICAL PHARMACOKINETIC MODELING [J].
BALANT, LP ;
GEXFABRY, M .
XENOBIOTICA, 1990, 20 (11) :1241-1257
[6]   PRECISION AND SENSITIVITY OF PHARMACOKINETIC MODELS FOR CANCER RISK ASSESSMENT - TETRACHLOROETHYLENE IN MICE, RATS, AND HUMANS [J].
BOIS, FY ;
ZEISE, L ;
TOZER, TN .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1990, 102 (02) :300-315
[7]   COMPARISON OF 3 PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS OF BENZENE DISPOSITION [J].
BOIS, FY ;
WOODRUFF, TJ ;
SPEAR, RC .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 110 (01) :79-88
[8]   BIOLOGICAL BASIS FOR EXTRAPOLATION ACROSS MAMMALIAN-SPECIES [J].
DAVIDSON, IWF ;
PARKER, JC ;
BELILES, RP .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1986, 6 (03) :211-237
[9]  
Devroye L., 1986, NONUNIFORM RANDOM VA
[10]  
DROZ PO, 1989, BRIT J IND MED, V46, P547